Antiretroviral choice for pregnant women with HIV does not appear to impact birth outcomes

One author reported stock from Abbott, AbbVie, Novartis, and Roche outside the submitted work; one author reported personal fees from Boehringer-Ingelheim; and five authors reported grants from pharmaceutical companies and Google outside the submitted work.

SOURCE: Rough K et al. N Engl J Med 2018;378:1593-603.